Skip to main content

Coronavirus vaccine with 50% or more efficacy would be a 'game changer,' says trial investigator

"A 50% efficacy would be transformative. It's much better than zero, which is what we have right now," Dr. Carlos del Rio of Emory University said on CNBC's "Squawk Box."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.